Cargando…
Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy.
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1990
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971399/ https://www.ncbi.nlm.nih.gov/pubmed/2138031 |
| _version_ | 1782134901836873728 |
|---|---|
| author | Smith, D. B. Newlands, E. S. Spruyt, O. W. Begent, R. H. Rustin, G. J. Mellor, B. Bagshawe, K. D. |
| author_facet | Smith, D. B. Newlands, E. S. Spruyt, O. W. Begent, R. H. Rustin, G. J. Mellor, B. Bagshawe, K. D. |
| author_sort | Smith, D. B. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-1971399 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1990 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-19713992009-09-10 Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. Smith, D. B. Newlands, E. S. Spruyt, O. W. Begent, R. H. Rustin, G. J. Mellor, B. Bagshawe, K. D. Br J Cancer Research Article Nature Publishing Group 1990-02 /pmc/articles/PMC1971399/ /pubmed/2138031 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Article Smith, D. B. Newlands, E. S. Spruyt, O. W. Begent, R. H. Rustin, G. J. Mellor, B. Bagshawe, K. D. Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. |
| title | Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. |
| title_full | Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. |
| title_fullStr | Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. |
| title_full_unstemmed | Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. |
| title_short | Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. |
| title_sort | ondansetron (gr38032f) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971399/ https://www.ncbi.nlm.nih.gov/pubmed/2138031 |
| work_keys_str_mv | AT smithdb ondansetrongr38032fplusdexamethasoneeffectiveantiemeticprophylaxisforpatientsreceivingcytotoxicchemotherapy AT newlandses ondansetrongr38032fplusdexamethasoneeffectiveantiemeticprophylaxisforpatientsreceivingcytotoxicchemotherapy AT spruytow ondansetrongr38032fplusdexamethasoneeffectiveantiemeticprophylaxisforpatientsreceivingcytotoxicchemotherapy AT begentrh ondansetrongr38032fplusdexamethasoneeffectiveantiemeticprophylaxisforpatientsreceivingcytotoxicchemotherapy AT rustingj ondansetrongr38032fplusdexamethasoneeffectiveantiemeticprophylaxisforpatientsreceivingcytotoxicchemotherapy AT mellorb ondansetrongr38032fplusdexamethasoneeffectiveantiemeticprophylaxisforpatientsreceivingcytotoxicchemotherapy AT bagshawekd ondansetrongr38032fplusdexamethasoneeffectiveantiemeticprophylaxisforpatientsreceivingcytotoxicchemotherapy |